Brisson, Ryan J.

Association of immune-related adverse events (irAEs) with improved response, progression-free survival, and overall survival for patients with metastatic head and neck cancer receiving anti-PD-1 therapy.

Foster, C. C., Kochanny, S., Khattri, A., Acharya, R., Dekker, A., Tan, Y.-H. C., Klema, E., Brisson, R. J., Saloura, V., Pearson, A. T., et al. (2018) · Journal of Clinical Oncology

Cancer Immunotherapy and BiomarkersHead and Neck Cancer Studies

Cited by 28